Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: Bridging the gap between neuroimaging and neuropathology

Schizophrenia Bulletin

Volumn 35, Issue 5, 2009, Pages 973-993

  Fornito, Alex ^a,d   Yücel, Murat ^a   Dean, Brian ^a,b,c   Wood, Stephen J ^a   Pantelis, Christos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d National Neuroscience Facility Australia   (Australia)

Author keywords

Glia; Limbic; Neuron; Prefrontal; Psychosis; VBM

Indexed keywords

BRAIN MAPPING; CINGULATE GYRUS; COGNITION; DENDRITE; HUMAN; NERVE CELL; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

AFFERENT PATHWAYS; CELL COUNT; DENDRITES; DOMINANCE, CEREBRAL; GYRUS CINGULI; HUMANS; LIMBIC SYSTEM; MAGNETIC RESONANCE IMAGING; NEUROGLIA; NEURONS; PREFRONTAL CORTEX; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPSES;

EID: 69249157220     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn025     Document Type: Review

References (222)

1. Harrison PJ. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain. 1999;122:593-624.
2. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
3. WrightIC,Rabe-HeskethS,WoodruffPW,DavidAS,Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry. 2000;157(1):16-25.
4. Pantelis C, Yucel M, Wood SJ, et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull. 2005;31(3):672-696.
5. ShentonME, DickeyCC, FruminM,McCarleyRW.Areview ofMRI findings in schizophrenia. SchizophrRes. 2001;49(1-2): 1-52.
6. Paus T. Primate anterior cingulate cortex: where motor control, drive and congition interface. NatRev Neurosci. 2001;2:417-424.
7. Ridderinkhof KR, Ullsperger M, Crone EA, Nieuwenhuis S. The role of the medial frontal cortex in cognitive control. Science. 2004;306(5695):443- 447.
8. Botvinick M, Braver TS, Barch DM, Carter CS, Cohen JD. Conflict monitoring and cognitive control. Psychol Rev. 2001;108(3):624-652.
9. Rushworth MF, Buckley MJ, Behrens TE, Walton ME, Bannerman DM. Functional organization of the medial frontal cortex. Curr Opin Neurobiol. 2007;17(2):220-227.
10. Walton ME, Croxson PL, Behrens TE, Kennerley SW, Rushworth MF. Adaptive decision making and value in the anterior cingulate cortex. Neuroimage. 2007;36:(suppl 2):T142-T154.
11. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain. 1995;118:279-306.
12. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4(6):215-222.
13. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2:435-443.
14. Amodio DM, Frith CD. Meeting of minds: the medial frontal cortex and social cognition. Nat Rev Neurosci. 2006;7(4):268-277.
15. Benes FM. The defects of affect and attention in schizophrenia: a possible neuroanatomical substrate. In: Matthysse S, Levy DL, Kagan J, Benes FM, eds. Psychopathology: The Evolving Science of Mental Disorder. New York, NY: Cambridge University Press; 1996:127-151.
16. Picard N, Strick PL. Motor areas of the medial wall: a review of their location and functional activation. Cereb Cortex. 1996;6(3):342-353.
17. Vogt BA. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci. 2005;6(7):533-544.
18. Andreasen NC, Paradiso S, O'Leary DS. "Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical- cerebellar circuitry? Schizophr Bull. 1998;24(2):203-218.
19. Todtenkopf MS, Vincent SL, Benes FM. A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res. 2005;73(1):79-89.
20. Broadbelt K, Byne W, Jones LB. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex. Schizophr Res. 2002;58(1):75-81.
21. Szeszko PR, Bilder RM, Lencz T, et al. Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia. Schizophr Res. 2000;43(2-3):97-108.
22. McGuire PK, Quested DJ, Spence SA, Murray RM, Frith CD, Liddle PF. Pathophysiology of 'positive' thought disorder in schizophrenia. Br J Psychiatry. 1998;173:231-235.
23. Snitz BE, MacDonald A, 3rd, Cohen JD, Cho RY, Becker T, Carter CS. Lateral and medial hypofrontality in firstepisode schizophrenia: functional activity in a medicationnaive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry. 2005;162(12):2322-2329.
24. Lahti AC, Holcomb HH, Weiler MA, et al. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology. 2004;29(1):171-178.
25. Drevets WC, Ongur D, Price JL. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry. 1998;3(3):190-191220-226.
26. Vogt BA, Nimchinsky EA, Vogt LJ, Hof PR. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol. 1995;359:490-506.
27. Yü cel M, Stuart GW, Maruff P, et al. Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study. Cereb Cortex. 2001;11:17-25.
28. Paus T, Tomaiuolo F, Otkay N, et al. Human cingulate and paracingulate sulci: pattern, variability, asymmetry, and probabilistic map. Cereb Cortex. 1996;6:207-214.
29. Fornito A, Yucel M, Wood SJ, et al. Morphology of the paracingulate sulcus and executive cognition in schizophrenia. Schizophr Res. 2006;88(1-3):192-197.
30. Fornito A, Yü cel M, Wood SJ, et al. Individual differences in anterior cingulate/paracingulate morphology are related to executive functions in healthy males. Cereb Cortex. 2004;14:424-431.
31. Heckers S, Weiss AP, Deckersbach T, Goff DC, Morecraft RJ, Bush G. Anterior cingulate cortex activation during cognitive interference in schizophrenia. Am J Psychiatry. 2004;161(4):707-715.
32. Yü cel M, Pantelis C, Stuart GW, et al. Anterior cingulate activation during stroop task performance: a PET to MRI coregistration study of individual patients with schizophrenia. Am J Psychiatry. 2002;159(2):251-254.
33. Artiges E, Martelli C, Naccache L, et al. Paracingulate sulcus morphology and fMRI activation detection in schizophrenia patients. Schizophr Res. 2006;82(2-3):143-151.
34. Fornito A, Wood SJ, Whittle S, et al. Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: associations with cortical thickness, surface area, volume and sulcal depth. Hum Brain Mapp. 2008;29(2):222-236.
35. Steele JD, Lawrie SM. Segregation of cognitive and emotional function in the prefrontal cortex: a stereotactic meta-analysis. Neuroimage. 2004;21(3):868-875.
36. Paus T, Koski L, Caramanos Z, Westbury C. Regional differences in the effects of task difficulty and motor output on blood flow response in the human anterior cingulate cortex: a review of 107 PET activation studies. Neuroreport. 1998;9(9):R37-R47.
37. Koski L, Paus T. Functional connectivity of the anterior cingulate cortex within the human frontal lobe: a brainmapping meta-analysis. Exp Brain Res. 2000;133:55-65.
38. Margulies DS, Kelly AM, Uddin LQ, Biswal BB, Castellanos FX, Milham MP. Mapping the functional connectivity of anterior cingulate cortex. Neuroimage. 2007; 37(2):579-588.
39. Gusnard DA, Akbudak E, Shulman GL, Raichle ME. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci U S A. 2001;98(7):4259-4264.
40. Gusnard DA, Raichle ME. Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci. 2001;2(10):685-694.
41. Critchley HD, Mathias CJ, Josephs O, et al. Human cingulate cortex and autonomic control: converging neuroimaging and clinical evidence. Brain. 2003;126(pt 10):2139-2152.
42. Mega MS, Cummings JL. The cingulate and cingulate syndromes. In: Trimble MR, Cummings JL, eds. Contemporary Behavioural Neurology. Boston, MA: Butterworth-Heinemann; 1997:189-213.
43. Crum WR, Griffin LD, Hill DLG, Hawkes DJ. Zen and the art of medical image registration: correspondance, homology, and quantity. Neuroimage. 2003;20:1425-1437.
44. Bookstein FL. "Voxel-based morphometry" should not be used with imperfectly registered images. Neuroimage. 2001;14(6):1454-1462.
45. Fornito A, Whittle S, Wood SJ, Velakoulis D, Pantelis C, Yucel M. The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex. Neuroimage. 2006;33(3):843-854.
46. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11(6 pt 1):805-821.
47. Thompson PM, Hayashi KM, Sowell ER, et al. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage. 2004;23:(suppl 1):S2-S18.
48. Davatzikos C, Genc A, Xu D, Resnick SM. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage. 2001;14(6):1361-1369.
49. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging. 1999;18(1):32-42.
50. Fischl B, Sereno MI, Tootell RBH, Dale AM. Highresolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 1999;8:272-284.
51. Zhou SY, Suzuki M, Hagino H, et al. Volumetric analysis of sulci/gyri-defined in vivo frontal lobe regions in schizophrenia: precentral gyrus, cingulate gyrus, and prefrontal region. Psychiatry Res. 2005;139(2):127-139.
52. Mitelman SA, Shihabuddin L, Brickman AM, Hazlett EA, Buchsbaum MS. Volume of the cingulate and outcome in schizophrenia. Schizophr Res. 2005;72(2-3):91-108.
53. Goldstein JM, Goodman JM, Seidman LJ, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry. 1999;56: 537-547.
54. Yamasue H, Iwanami A, Hirayasu Y, et al. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res. 2004;131(3):195-207.
55. Suzuki M, Zhou SY, Hagino H, et al. Morphological brain changes associated with Schneider's first-rank symptoms in schizophrenia: a MRI study. Psychol Med. 2005;35(4): 549-560.
56. Fujiwara H, Hirao K, Namiki C, et al. Anterior cingulate pathology and social cognition in schizophrenia: a study of gray matter, white matter and sulcal morphometry. Neuroimage. 2007;36(4):1236-1245.
57. Szeszko PR, Robinson DG, Sevy S, et al. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry. 2007;190:230-236.
58. Wang L, Hosakere M, Trein JC, et al. Abnormalities of cingulate gyrus neuroanatomy in schizophrenia. Schizophr Res. 2007;93(1-3):66-78.
59. Qiu A, Younes L, Wang L, et al. Combining anatomical manifold information via diffeomorphic metric mappings for studying cortical thinning of the cingulate gyrus in schizophrenia. Neuroimage. 2007;37(3):821-833.
60. Convit A, Wolf OT, de Leon MJ, et al. Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. Psychiatry Res. 2001;107(2):61-73.
61. Riffkin J, Yü cel M, Maruff P, et al. A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia. Psychiatry Res. 2005;138:99-113.
62. Szendi I, Kiss M, Racsmany M, et al. Correlations between clinical symptoms, working memory functions and structural brain abnormalities in men with schizophrenia. Psychiatry Res. 2006;147(1):47-55.
63. Haznedar MM, Buchsbaum MS, Hazlett EA, Shihabuddin L, New A, Siever LJ. Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res. 2004;71(2-3):249-262.
64. Takahashi T, Kawasaki Y, Kurokawa K, et al. Lack of normal structural asymmetry of the anterior cingulate gyrus in female patients with schizophrenia: a volumetric magnetic resonance imaging study. Schizophr Res. 2002;55(1-2):69-81.
65. Choi JS, Kang DH, Kim JJ, et al. Decreased caudal anterior cingulate gyrus volume and positive symptoms in schizophrenia. Psychiatry Res. 2005;139(3):239-247.
66. Noga JT, Aylward E, Barta PE, Pearlson GD. Cingulate gyrus in schizophrenic patients and normal volunteers. Psychiatry Res. 1995;61(4):201-208.
67. Crespo-Facorro B, Kim J, Andreasen NC, O'Leary DS, Magnotta V. Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study. Biol Psychiatry. 2000;48(2):110-119.
68. Fornito A, Yü cel M, Wood SJ, et al. Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp. 2008;29(4):478-489.
69. Takahashi T, Suzuki M, Kawasaki Y, et al. Perigenual cingulate gyrus volume in patients with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry. 2003; 53(7):593-600.
70. Kopelman A, Andreasen NC, Nopoulos P. Morphology of the anterior cingulate gyrus in patients with schizophrenia: relationship to typical neuroleptic exposure. Am J Psychiatry. 2005;162(10):1872-1878.
71. Hirayasu Y, Shenton ME, Salisbury DF, et al. Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry. 1999;156(7):1091- 1093.
72. Coryell W, Nopoulos P, Drevets W, Wilson T, Andreasen NC. Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry. 2005;162(9): 1706-1712.
73. Lopez-Garcia P, Aizenstein HJ, Snitz BE, Walter RP, Carter CS. Automated ROI-based brain parcellation analysis of frontal and temporal brain volumes in schizophrenia. Psychiatry Res. 2006;147(2-3):153-161.
74. Yü cel M, Stuart GW, Maruff P, et al. Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biol Psychiatry. 2002;52:15-23.
75. Le Provost JB, Bartres-Faz D, Paillere-Martinot ML, et al. Paracingulate sulcus morphology in men with early-onset schizophrenia. Br J Psychiatry. 2003;182:228-232.
76. Goghari VM, Rehm K, Carter CS, MacDonald AW, 3rd. Regionally specific cortical thinning and gray matter abnormalities in the healthy relatives of schizophrenia patients. Cereb Cortex. 2007;17(2):415-424.
77. McIntosh AM, Job DE, Moorhead TW, Harrison LK, Forrester K,LawrieSM, JohnstoneEC.Voxel-basedmorphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives. Biol Psychiatry. 2004;56(8):544-552.
78. McIntosh AM, Job DE, Moorhead WJ, et al. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure. Am J Med Genet B Neuropsychiatr Genet. 2006;141(1):76-83.
79. McDonald C, Bullmore ET, Sham PC, et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry. 2004;61(10):974-984.
80. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM. Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia. Schizophr Res. 2003;64(1):1-13.
81. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281-288.
82. Yung AR, Phillips LJ, McGorry PD, et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl. 1998;172(33):14-20.
83. Borgwardt SJ, Riecher-Rossler A, Dazzan P, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry. 2007;61(10):1148-1156.
84. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage. 2005;25(4):1023-1030.
85. Fornito A, Malhi GS, Lagopoulos J, et al. Anatomical abnormalities of the anterior cingulate cortex and paracingulate cortex in patients with bipolar I disorder. Psychiatry Res. 2008;162(2):123-132.
86. Kawasaki Y, Suzuki M, Nohara S, et al. Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. Eur Arch Psychiatry Clin Neurosci. 2004;254(6):406-414.
87. Yoneyama E, Matsui M, Kawasaki Y, et al. Gray matter features of schizotypal disorder patients exhibiting the schizophrenia-related code types of the Minnesota Multiphasic Personality Inventory. Acta Psychiatr Scand. 2003; 108(5):333-340.
88. Takahashi T, Suzuki M, Kawasaki Y, et al. Volumetric magnetic resonance imaging study of the anterior cingulate gyrus in schizotypal disorder. Eur Arch Psychiatry Clin Neurosci. 2002;252(6):268-277.
89. Farrow TF, Whitford TJ, Williams LM, Gomes L, Harris AW. Diagnosis-related regional gray matter loss over two years in first episode schizophrenia and bipolar disorder. Biol Psychiatry. 2005;58(9):713-723.
90. Whitford TJ, Grieve SM, Farrow TF, et al. Progressive grey matter atrophy over the first 2-3 years of illness in firstepisode schizophrenia: a tensor-based morphometry study. Neuroimage. 2006;32(2):511-519.
91. van Haren NE, Hulshoff Pol HE, Schnack HG, et al. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study. Neuropsychopharmacology. 2007;32(10):2057-2066.
92. McCormick L, Decker L, Nopoulos P, Ho BC, Andreasen N. Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. Schizophr Res. 2005; 80(1):73-84.
93. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59:533-558.
94. Sowell ER, Thompson PM, Toga AW. Mapping changes in the human cortex throughout the span of life. Neuroscientist. 2004;10(4):372-392.
95. Paus T, Collins DL, Evans AC, Leonard G, Pike B, Zijdenbos A. Maturation of white matter in the human brain: a review of magnetic resonance studies. Brain Res Bull. 2001;54(3):255-266.
96. Stark AK, Uylings HB, Sanz-Arigita E, Pakkenberg B. Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry. 2004;161(5):882-888.
97. Highley JR, Walker MA, Esiri MM, McDonald B, Harrison PJ, Crow TJ. Schizophrenia and the frontal lobes: postmortem stereological study of tissue volume. Br J Psychiatry. 2001;178:337-343.
98. Kreczmanski P, Schmidt-Kastner R, Heinsen H, Steinbusch HW, Hof PR, Schmitz C. Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathol. 2005;109(5):510-518.
99. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95(22):13290-13295.
100. Bouras C, Kovari E, Hof PR, Riederer BM, Giannakopoulos P. Anterior cingulate cortex pathology in schizophrenia and bipolar disorder. Acta Neuropathol (Berl). 2001;102(4): 373-379.
101. Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry. 2001;50(6):395-406.
102. West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999;22(2):51-61.
103. Benes FM, Lange N. Two-dimensional versus threedimensional cell counting: a practical perspective. Trends Neurosci. 2001;24(1):11-17.
104. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 1986;43(1):31-35.
105. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48(11):996-1001.
106. Chana G, Landau S, Beasley C, Everall IP, Cotter D. Twodimensional assessment of cytoarchitecture in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia: evidence for decreased neuronal somal size and increased neuronal density. Biol Psychiatry. 2003;53(12):1086-1098.
107. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry. 2001;58(6):545-553.
108. Jones LB, Johnson N, Byne W. Alterations in MAP2 immunocytochemistry in areas 9 and 32 of schizophrenic prefrontal cortex. Psychiatry Res. 2002;114(3):137-148.
109. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry. 1999;45(1):17-25.
110. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2004;61(7):649-657.
111. Benes FM, Bird ED. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry. 1987;44(7):608-616.
112. Seldon HL. Does brain white matter growth expand the cortex like a balloon? Hypothesis and consequences. Laterality. 2005;10(1):81-95.
113. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005;10(1):40-68.
114. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res. 2006;81(1):47-63.
115. Aganova EA, Uranova NA. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol. 1992;22(1):59-65.
116. Landen M, Davidsson P, Gottfries CG, Mansson JE, Blennow K. Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia. Schizophr Res. 2002;55(1-2):83-88.
117. Davidsson P, Gottfries J, Bogdanovic N, et al. The synapticvesicle- specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res. 1999;40(1):23-29.
118. Blennow K, Bogdanovic N, Heilig M, Grenfeldt B, Karlsson I, Davidsson P. Reduction of the synaptic protein rab3a in the thalamus and connecting brain regions in post-mortem schizophrenic brains. J Neural Transm. 2000;107(8-9): 1085-1097.
119. Benes FM, Majocha R, Bird ED, Marotta CA. Increased vertical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry. 1987;44(11):1017-1021.
120. Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb Cortex. 1992;2(6):503-512.
121. Benes FM, Todtenkopf MS, Taylor JB. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse. 1997;25(1):80-92.
122. Dazzan P, Morgan KD, Orr K, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005;30(4):765-774.
123. Selemon LD, Lidow MS, Goldman-Rakic PS. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry. 1999;46(2):161-172.
124. Glantz LA, Lewis DA. Dendritic spine density in schizophrenia and depression. Arch Gen Psychiatry. 2001;58(2):203.
125. Cullen TJ, Walker MA, Eastwood SL, Esiri MM, Harrison PJ, Crow TJ. Anomalies of asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in schizophrenia. Br J Psychiatry. 2006;188:26-31.
126. Miguel-Hidalgo JJ, Dubey P, Shao Q, Stockmeier C, Rajkowska G. Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression. Schizophr Res. 2005;76(2-3):159-171.
127. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 2002;12(4): 386-394.
128. Selemon LD, Rajkowska G, Goldman-Rakic PS. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comp Neurol. 1998;392(3): 402-412.
129. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry. 1998;55(3):215-224.
130. Longson D, Deakin JF, Benes FM. Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia. J Neural Transm. 1996;103(4):503-507.
131. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Rev. 2000;31(2-3):251-269.
132. Selemon LD. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr Bull. 2001;27(3):349-377.
133. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6(3):309-315.
134. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci. 2005;9(2):60-68.
135. Braitenberg V. Brain size and number of neurons: an exercise in synthetic neuroanatomy. J Comp Neurosci. 2001; 10(1):71-77.
136. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004;101(21): 8174-8179.
137. Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci. 2004;24(38):8223-8231.
138. Sowell ER, Thompson PM, Tessner KD, Toga AW. Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci. 2001;21(22): 8819-8829.
139. Huttenlocher PR. Synaptic density in human frontal cortex-developmental changes and effects of aging. Brain Res. 1979;163(2):195-205.
140. Huttenlocher PR. Morphometric study of human cerebral cortex development. Neuropsychologia. 1990;28(6):517-527.
141. Vidal CN, Rapoport JL, Hayashi KM, et al. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Arch Gen Psychiatry. 2006; 63(1):25-34.
142. Benes FM. Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull. 1989;15(4):585-593.
143. Cunningham MG, Bhattacharyya S, Benes FM. Amygdalocortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J Comp Neurol. 2002;453(2): 116-130.
144. McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry. 2000;57(7):637-648.
145. Benes FM, Walsh J, Bhattacharyya S, Sheth A, Berretta S. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch Gen Psychiatry. 2003;60(4):359-364.
146. Benes FM, Matzilevich D, Burke RE, Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry. 2006;11(3): 241-251.
147. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl-2 ratio without caspase-3 activation. Am J Psychiatry. 2004;161(1):109-115.
148. Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry. 2000;48(7):641-650.
149. Jarskog LF. Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations. Curr Opin Psychiatry. 2006; 19(3):307-312.
150. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5): 846-858.
151. Olney JW. Excitotoxicity, apoptosis and neuropsychiatric disorders. Curr Opin Pharmacol. 2003;3(1):101-109.
152. Buss RR, Sun W, Oppenheim RW. Adaptive roles of programmed cell death during nervous system development. Annu Rev Neurosci. 2006;29:1-35.
153. McLaughlin B. The kinder side of killer proteases: caspase activation contributes to neuroprotection and CNS remodeling. Apoptosis. 2004;9(2):111-121.
154. Stahl SM. Beyond the dopamine hypothesis to the NMDA glutamate receptor hypofunction hypothesis of schizophrenia. CNS Spectr. 2007;12(4):265-268.
155. Javitt DC. Glutamate and schizophrenia: phencyclidine, Nmethyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol. 2007;78:69-108.
156. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl). 2003;169(3-4):215-233.
157. Farber NB, Kim SH, Dikranian K, Jiang XP, Heinkel C. Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry. 2002;7(1):32-43.
158. Allen RM, Young SJ. Phencyclidine-induced psychosis. Am J Psychiatry. 1978;135(9):1081-1084.
159. Luisada PV. The phencyclidine psychosis: phenomenology and treatment. NIDA Res Monogr. 1978;21:241-253.
160. Luisada PV, Brown BI. Clinical management of the phencyclidine psychosis. Clin Toxicol. 1976;9(4):539-545.
161. Erard R, Luisada PV, Peele R. The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? J Psychedelic Drugs. 1980;12(3-4):235-251.
162. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology. 2001;25(4): 455-467.
163. Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 1995;13(1):9-19.
164. Fix AS, Wightman KA, O'Callaghan JP. Reactive gliosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex: GFAP evaluation by sandwich ELISA and immunocytochemistry. Neurotoxicology. 1995;16(2): 229-237.
165. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
166. Farber NB, Wozniak DF, Price MT. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry. 1995;38(12):788-796.
167. Schurhoff F, Golmard JL, Szoke A, et al. Admixture analysis of age at onset in schizophrenia. Schizophr Res. 2004; 71(1):35-41.
168. Karp HN, Kaufman ND, Anand SK. Phencyclidine poisoning in young children. J Pediatr. 1980;97(6):1006-1009.
169. Welch MJ, Correa GA. PCP intoxication in young children and infants. Clin Pediatr (Phila). 1980;19(8):510-514.
170. Holcomb HH, Lahti AC, Medoff DR, Weiler M, Tamminga CA. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology. 2001;25(2): 165-172.
171. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 1995;6(6):869-872.
172. Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology. 2005;30(12): 2275-2282.
173. Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology. 1997;16(5):357-372.
174. Theberge J, Bartha R, Drost DJ, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry. 2002;159(11):1944-1946.
175. Bartha R, Williamson PC, Drost DJ, et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 1997;54(10):959-965.
176. Rowland LM, Bustillo JR, Mullins PG, et al. Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. Am J Psychiatry. 2005;162(2):394-396.
177. Hajszan T, Leranth C, Roth RH. Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex. Biol Psychiatry. 2006;60(6): 639-644.
178. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283(5398):70-74.
179. Holmes CJ, Hoge R, Collins L, Woods R, Toga AW, Evans AC. Enhancement of MR images using registration for signal averaging. J Comp Assist Tomogr. 1998;22(2):324-333.
180. Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK. Mapping of grey matter changes in schizophrenia. Schizophr Res. 1999;35:1-14.
181. Sowell ER, Levitt J, Thompson PM, et al. Brain abnormalities in early-onset schizophrenia spectrum disorder observed with statistical parametric mapping of structural magnetic resonance images. Am J Psychiatry. 2000;157(9): 1475-1484.
182. Foong J, Symms MR, Barker GJ, et al. Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. Brain. 2001;124(pt 5):882-892.
183. Hulshoff Pol HE, Schnack HG, Mandl RC, et al. Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry. 2001;58(12):1118-1125.
184. Paillere-Martinot M, Caclin A, Artiges E, et al. Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. Schizophr Res. 2001;50(1-2):19-26.
185. Sigmundsson T, Suckling J, Maier M, et al. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am J Psychiatry. 2001; 158(2):234-243.
186. Wilke M, Kaufmann C, Grabner A, Putz B, Wetter TC, Auer DP. Gray matter-changes and correlates of disease severity in schizophrenia: a statistical parametric mapping study. Neuroimage. 2001;13(5):814-824.
187. Ananth H, Popescu I, Critchley HD, Good CD, Frackowiak RS, Dolan RJ. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry. 2002;159(9): 1497-1505.
188. Job DE, Whalley HC, McConnell S, Glabus M, Johnstone EC, Lawrie SM. Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry. Neuroimage. 2002;17(2): 880-889.
189. Kubicki M, Shenton ME, Salisbury DF, et al. Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage. 2002;17(4):1711-1719.
190. Shapleske J, Rossell SL, Chitnis XA, et al. A computational morphometric MRI study of schizophrenia: effects of hallucinations. Cereb Cortex. 2002;12(12):1331-1341.
191. Suzuki M, Nohara S, Hagino H, et al. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res. 2002;55(1-2):41-54.
192. Bagary MS, Symms MR, Barker GJ, Mutsatsa SH, Joyce EM, Ron MA. Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Arch Gen Psychiatry. 2003;60(8): 779-788.
193. Kuperberg GR, Broome MR, McGuire PK, et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry. 2003;60:878-888.
194. Marcelis M, Suckling J, Woodruff P, Hofman P, Bullmore E, van Os J. Searching for a structural endophenotype in psychosis using computational morphometry. Psychiatry Res. 2003;122(3):153-167.
195. Salgado-Pineda P, Baeza I, Perez-Gomez M, et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage. 2003;19(2 pt 1):365-375.
196. Ha TH, Youn T, Ha KS, et al. Gray matter abnormalities in paranoid schizophrenia and their clinical correlations. Psychiatry Res. 2004;132(3):251-260.
197. Moorhead TW, Job DE, Whalley HC, Sanderson TL, Johnstone EC, Lawrie SM. Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods. Neuroimage. 2004;22(1): 188-202.
198. Salgado-Pineda P, Junque C, Vendrell P, et al. Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients. Neuroimage. 2004;21(3):840-847.
199. Antonova E, Kumari V, Morris R, et al. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry. 2005; 58(6):457-467.
200. Davatzikos C, Shen D, Gur RC, et al. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry. 2005; 62(11):1218-1227.
201. Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(4):587-591.
202. McDonald C, Bullmore E, Sham P, et al. Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry. 2005;186:369-377.
203. Narr KL, Toga AW, Szeszko P, et al. Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol Psychiatry. 2005;58(1):32-40.
204. Whitford TJ, Farrow TF, Gomes L, Brennan J, Harris AW, Williams LM. Grey matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res. 2005;139(3): 229-238.
205. Neckelmann G, Specht K, Lund A, et al. MR morphometry analysis of grey matter volume reduction in schizophrenia: association with hallucinations. Int J Neurosci. 2006; 116(1):9-23.
206. Ohnishi T, Hashimoto R, Mori T, et al. The association between the Val158Met polymorphism of the catechol-Omethyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain. 2006;129(pt 2): 399-410.
207. Park HJ, Lee JD, Chun JW, et al. Cortical surface-based analysis of 18F-FDG PET: measured metabolic abnormalities in schizophrenia are affected by cortical structural abnormalities. Neuroimage. 2006;31(4):1434-1444.
208. Chua SE, Cheung C, Cheung V, et al. Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia. Schizophr Res. 2007;89(1-3):12-21.
209. Kasparek T, Prikryl R, Mikl M, Schwarz D, Ceskova E, Krupa P. Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):151-157.
210. Kawasaki Y, Suzuki M, Kherif F, et al. Multivariate voxelbased morphometry successfully differentiates schizophrenia patients from healthy controls. Neuroimage. 2007;34(1): 235-242.
211. Pagsberg AK, Baare WF, Raabjerg Christensen AM, et al. Structural brain abnormalities in early onset first-episode psychosis. J Neural Transm. 2007;114(4):489-498.
212. Yamada M, Hirao K, Namiki C, et al. Social cognition and frontal lobe pathology in schizophrenia: a voxel-based morphometric study. Neuroimage. 2007;35(1):292-298.
213. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14(1 pt 1):21-36.
214. Talairach J, Tournoux P. Co-planar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme; 1988.
215. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci. 2002;3(3):243-249.
216. Szeszko PR, Bilder RM, Lencz T, et al. Investigation of frontal lobe subregions in first-episode schizophrenia. Psychiatry Res. 1999;90:1-15.
217. Marquardt RK, Levitt JG, Blanton RE, et al. Abnormal development of the anterior cingulate in childhood-onset schizophrenia: a preliminary quantitative MRI study. Psychiatry Res. 2005;138(3):221-233.
218. Yamasue H, Fukui T, Fukuda R, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport. 2002;13(16):2133-2137.
219. Caviness VS, Jr, Meyer J, Makris N, Kennedy DN. MRIbased topographic parcellation of human neocortex: An anatomically specified method with estimate of reliability. J Cogn Neurosci. 1996;8(6):566-587.
220. Crespo-Facorro B, Kim JJ, Andreasen NC, et al. Human frontal cortex: an MRI-based parcellation method. Neuroimage. 1999;10:500-519.
221. Takahashi T, Suzuki M, Zhou SY, et al. Lack of normal gender differences of the perigenual cingulate gyrus in schizophrenia spectrum disorders. A magnetic resonance imaging study. Eur Arch Psychiatry Clin Neurosci. 2004; 254(5):273-280.
222. Steiner J, Mawrin C, Ziegeler A, et al. Distribution of HLADR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006;112(3): 305-316.